Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab
2018 ◽
Vol 24
(3)
◽
pp. S337
2009 ◽
Vol 37
(5)
◽
pp. E181-E182
2016 ◽
Vol 38
(11)
◽
pp. 2468-2476
◽
2009 ◽
Vol 37
(4)
◽
pp. 327-334
◽
2006 ◽
Vol 38
(12)
◽
pp. 813-819
◽
2012 ◽
Vol 40
(5)
◽
pp. 434-439
◽
2006 ◽
Vol 37
(6)
◽
pp. 595-599
◽